Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-04-07Clinical Trial Update: Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785) [Phase 3]
Phase 3 clinical trial update investigating long-term efficacy and safety of asenapine with haloperidol as a positive control in schizophren…
-
CLINICAL_TRIALS trial_result · 2010-03-26Clinical Trial Update: Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic Patients [Phase 1]
A completed Phase 1 pharmacokinetics study evaluating quetiapine fumarate in Chinese patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2010-03-25Clinical Trial Update: Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771) [Phase 3]
Phase 3 trial comparing asenapine to olanzapine for persistent negative symptoms in schizophrenia; study completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2010-03-25Clinical Trial Update: An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications. [Phase 4]
This update notes the completion of an open-label Phase 4 trial evaluating metformin for weight control in pediatric patients on antipsychot…
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: The Effects of Aripiprazole on Patients With Metabolic Syndrome [Phase 4]
Phase 4 trial update assessing the effects of aripiprazole in patients with metabolic syndrome. The study involves conditions including schi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia
This completed clinical trial evaluated whether daily SMS reminders improve adherence to oral antipsychotics in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2010-03-19Clinical Trial Update: Multiple Dose Safety Study of PF-04802540 in Subjects With Schizophrenia [Phase 1]
Phase 1 multiple-dose safety study of PF-04802540 in subjects with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-16Clinical Trial Update: Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia [Phase 4]
A Phase 4 study compared Risperdal Consta (risperidone long-acting injectable) to Abilify (aripiprazole) over two years in patients with sch…
-
CLINICAL_TRIALS research · 2010-03-12Clinical Trial Update: A Non-interventional Study Evaluating the Clinical Benefit and Effectiveness of Quetiapine Fumarate Extended
A non-interventional study assessing the clinical benefit and effectiveness of quetiapine fumarate extended-release in schizophrenia has com…
-
CLINICAL_TRIALS research · 2010-03-10Clinical Trial Update: Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype [Phase 4]
An update on a Phase 4 clinical trial evaluating an antidepressant treatment for the negative symptoms of schizophrenia in patients with an …
-
CLINICAL_TRIALS trial_result · 2010-03-09Clinical Trial Update: Is MS14 Helpful in Schizophrenia? [Phase 2]
Phase 2 trial update evaluating MS14 for schizophrenia. No results are reported yet.
-
CLINICAL_TRIALS research · 2010-03-08Clinical Trial Update: A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations
This clinical trial update describes a neurobiological study of schizophrenia examining genetic variations and neurobiological differentiati…
-
CLINICAL_TRIALS trial_result · 2010-03-05Clinical Trial Update: Assertive Community Treatment (ACT) in Schizophrenia Spectrum Disorders [Phase 4]
Phase 4 clinical trial evaluating Assertive Community Treatment for schizophrenia has been completed.
-
CLINICAL_TRIALS trial_result · 2010-03-03Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) in Schizophrenia [Phase 2, Phase 3]
This clinical trial update reports ongoing Phase 2 and Phase 3 studies evaluating transcranial magnetic stimulation for schizophrenia; no re…
-
FDA approval · 2010-02-26FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for HALOPERIDOL DECANOATE from Mylan Institutional LLC under an ANDA, confirming approval of this ge…
-
CLINICAL_TRIALS trial_result · 2010-02-26Clinical Trial Update: An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of a single dosage of Paliperidone ER in adults with schizophrenia; results were p…
-
CLINICAL_TRIALS trial_result · 2010-02-23Clinical Trial Update: 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777) [Phase 3]
Phase 3 extension trial of asenapine with olanzapine in schizophrenia patients who completed the protocol; results posted in 2010.
-
FDA approval · 2010-02-19FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals, LLC's supplemental application for risperidone (ANDA 078707). This action represents an approval r…
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia [NA]
A completed clinical trial assessing pergolide as adjuvant therapy for cognitive deficits in schizophrenia.
-
CLINICAL_TRIALS research · 2010-02-05Clinical Trial Update: Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR
A completed non-interventional observational study evaluating the effectiveness of Seroquel XR (quetiapine extended-release) in maintaining …
-
CLINICAL_TRIALS research · 2010-02-04Clinical Trial Update: Epidemiology of Schizophrenia in Bulgaria
AstraZeneca-sponsored epidemiology study on schizophrenia in Bulgaria has completed.
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone [Phase 4]
A Phase 4 trial evaluating safety, tolerability, and efficacy of switching from quetiapine to ziprasidone in schizophrenia and schizoaffecti…
-
FDA approval · 2010-01-29FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Haloperidol Decanoate by Hikma Pharmaceuticals USA Inc. (AP status: AP).
-
FDA approval · 2010-01-27FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Zyprexa Intramuscular (olanzapine) submitted by Eli Lilly.
-
FDA approval · 2010-01-27FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA ZYDIS (olanzapine) submitted by Eli Lilly and Company.